PAS1C1 anticorps (Middle Region)
Aperçu rapide pour PAS1C1 anticorps (Middle Region) (ABIN1450045)
Antigène
Voir toutes PAS1C1 (IFLTD1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, Mouse, Rat.
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogène
- 19 amino acid synthetic peptide near the center of Human IFLTD1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PAS1C1 (IFLTD1) (Intermediate Filament Tail Domain Containing 1 (IFLTD1))
-
Autre désignation
- IFLTD1
-
Sujet
- The intermediate filament tail domain-containing protein (IFLTD1) was initially identified as a candidate gene for pulmonary adenoma susceptibility 1 gene in mice. Transcripts of the gene were only detected in mouse lung tissue from strains carrying the Pas1-susceptible allele. Expression of different alleles of this gene in lung cancer cell lines resulted in different levels of colony formation in in vitro colony formation assays, suggesting that allelic variants of this gene can modulate growth of human cancer cells.Synonyms: Intermediate filament tail domain-containing protein 1
-
ID gène
- 160492
-
NCBI Accession
- NP_001139200
Antigène
-